>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

October 13, 2014

FDA MedWatch - ICU Medical ConMed Stat2 Flow Controller: Class 1 Recall - Delivers Higher Flow Rate than Intended

Summary:

FDA MedWatch ICU Medical ConMed Stat2 Flow Controller

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Urges Issuance of Federal Fraud Alert on the 'Company Model'

Wednesday, February 26, 2014

On February 25, ASA formally urged the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) to issue a special fraud alert regarding the "company model" and to modify existing safe harbors to prevent referring physicians from profiting from their referrals for anesthesia services.

ASA filed these comments in response to the December 27, 2013 HHS-OIG solicitation for new potential safe harbors, modification to existing safe harbors, and special fraud alerts. Under the company model, referring physicians, who typically also own the facility where surgical procedures are performed, form a separate anesthesia company in order to share in anesthesia revenue. 

Over the past two years the HHS-OIG has issued two advisory opinions on the company model.  Advisory Opinion No. 12-06, issued in June 2012 and Advisory Opinion No. 13-15 issued last November.

ASA has serious concerns about the impact of the company model, and variations of that arrangement, on anesthesiologists, the patients they serve, and the integrity and fiscal soundness of Federal health care programs.  ASA has consistently advocated against company model arrangements.

Review ASA’s formal comments to HHS-OIG Inspector General Levinson dated February 25, 2014. 

Review the HHS-OIG Notice. 

Review ASA’s formal comments to HHS-OIG Inspector General Levinson dated February 26, 2013.

Review ASA's formal communication to Inspector General Levinson dated February 27, 2012.

Review the updated Company Model FAQ.

Watch the Special Company Model Webinar Presentation.


« Back to Washington Alerts